Pharmacological properties of substituted gamma-butyrolactones. Part II. Antoconvulsant action.
D000498:Allyl Compounds / Q000627:therapeutic use; D000818:Animals; D000927:Anticonvulsants; D001534:Bemegride; D055598:Chemical Phenomena; D002621:Chemistry; D004353:Drug Evaluation, Preclinical; D004558:Electric Stimulation / Q000009:adverse effects; D005663:Furans / Q000627:therapeutic use* / Q000633:toxicity; D006801:Humans; D007783:Lactones / Q000627:therapeutic use* / Q000633:toxicity; D008297:Male; D051379:Mice; D010433:Pentylenetetrazole; D012640:Seizures / Q000139:chemically induced / Q000188:drug therapy / Q000209:etiology; D013331:Strychnine
D000498:Allyl Compounds; D000927:Anticonvulsants; D005663:Furans; D007783:Lactones; D001534:Bemegride; D013331:Strychnine; D010433:Pentylenetetrazole